300434 Stock Overview
Sichuan Goldstone Asia Pharmaceutical Inc. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Sichuan Goldstone Asia Pharmaceutical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.25 |
| 52 Week High | CN¥11.29 |
| 52 Week Low | CN¥6.72 |
| Beta | 0.30 |
| 1 Month Change | -10.52% |
| 3 Month Change | -8.23% |
| 1 Year Change | -25.27% |
| 3 Year Change | -24.93% |
| 5 Year Change | 7.98% |
| Change since IPO | 95.14% |
Recent News & Updates
Sichuan Goldstone Asia Pharmaceutical's (SZSE:300434) Conservative Accounting Might Explain Soft Earnings
Nov 02
There's Reason For Concern Over Sichuan Goldstone Asia Pharmaceutical Inc.'s (SZSE:300434) Massive 42% Price Jump
Oct 08Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Has A Pretty Healthy Balance Sheet
Sep 30Recent updates
Sichuan Goldstone Asia Pharmaceutical's (SZSE:300434) Conservative Accounting Might Explain Soft Earnings
Nov 02There's Reason For Concern Over Sichuan Goldstone Asia Pharmaceutical Inc.'s (SZSE:300434) Massive 42% Price Jump
Oct 08Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Has A Pretty Healthy Balance Sheet
Sep 30Sichuan Goldstone Asia Pharmaceutical's (SZSE:300434) Conservative Accounting Might Explain Soft Earnings
May 02Shareholder Returns
| 300434 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.5% | -0.08% | 1.0% |
| 1Y | -25.3% | -6.0% | 8.2% |
Return vs Industry: 300434 underperformed the CN Pharmaceuticals industry which returned -6% over the past year.
Return vs Market: 300434 underperformed the CN Market which returned 8.2% over the past year.
Price Volatility
| 300434 volatility | |
|---|---|
| 300434 Average Weekly Movement | 7.7% |
| Pharmaceuticals Industry Average Movement | 6.7% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CN Market | 12.2% |
| 10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 300434 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300434's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,962 | Yiping Ma | www.goldstone-group.com |
Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, and sale of medicines and health products in China. It produces and sells plastic composite pipes, pipe fittings and equipment, as well as develops vacuum coating, industrial machinery, pipe fitting molds, construction equipment, and special equipment. The company produces, installs, and maintains special equipment.
Sichuan Goldstone Asia Pharmaceutical Inc. Fundamentals Summary
| 300434 fundamental statistics | |
|---|---|
| Market cap | CN¥3.31b |
| Earnings (TTM) | CN¥45.55m |
| Revenue (TTM) | CN¥1.14b |
72.8x
P/E Ratio2.9x
P/S RatioIs 300434 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300434 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.14b |
| Cost of Revenue | CN¥475.42m |
| Gross Profit | CN¥663.36m |
| Other Expenses | CN¥617.82m |
| Earnings | CN¥45.55m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 25, 2025
| Earnings per share (EPS) | 0.11 |
| Gross Margin | 58.25% |
| Net Profit Margin | 4.00% |
| Debt/Equity Ratio | 1.0% |
How did 300434 perform over the long term?
See historical performance and comparisonDividends
1.3%
Current Dividend Yield102%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 21:50 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sichuan Goldstone Asia Pharmaceutical Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|